Hi Jin12345
I was also pessimistic after listening in on the conference call this morning.
In regards to positive clinical data I personally think this is very likely given the Sirflox trial has already shown an increase in progression free survival in the liver of 7.9 months.
I would be very surprised if this doesn't result in a very good increase in overall survival and a move for Sirspheres into standard of care/first line treatment.
Massive Overreaction!, page-4
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 17.5¢ | 17.5¢ | $290.8K | 1.662M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100853 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 1326027 | 33 |
View Market Depth
| Last trade - 15.53pm 29/08/2024 (20 minute delay) ? |
| SRX (ASX) Chart |